[Form 4] HAEMONETICS CORP Insider Trading Activity

Rhea-AI Filing Summary

Haemonetics insider transaction summary: Laurie A. Miller, SVP, Human Resources at Haemonetics Corp (HAE), reported a Form 4 showing a tax-withholding disposition tied to the vesting of restricted stock units. On 09/17/2025, 238 shares were disposed (transaction code F) at a price of $49.95 per share to satisfy tax obligations related to vested RSUs. After that transaction, Ms. Miller beneficially owned 28,925 shares, which the filing notes includes unvested RSUs previously reported. The Form 4 was signed by attorney-in-fact Thomas V. Powers on 09/24/2025.

Positive

• Retained significant ownership: Reporting person still beneficially owns 28,925 shares including unvested RSUs, indicating continued alignment with shareholders
• Transaction was tax-related: The 238-share disposition was for tax withholding on RSU vesting, not an open-market sale for diversification

Negative

• Minor reduction in reported holdings: 238 shares were disposed to satisfy tax obligations, slightly decreasing immediate share count

Insights

Corporate Governance Expert

TL;DR: Routine tax-withholding sale on RSU vesting; maintains meaningful insider ownership without leadership change.

The filing documents a standard withholding disposition tied to RSU vesting rather than an open-market sale for cash. Such transactions are common for executives to satisfy tax obligations and do not indicate a change in company control or executive status. The reported beneficial ownership of 28,925 shares, including unvested RSUs, suggests continued alignment with shareholder interests. No material governance or compliance issues are apparent from the filing alone.

Securities Analyst

TL;DR: Small, non-material disposal of shares at $49.95 due to tax withholding; neutral for valuation or liquidity.

The disposition of 238 shares at $49.95 appears to be a tax-withholding event connected to RSU vesting and is labeled with transaction code F, consistent with withholding. The remaining beneficial ownership figure of 28,925 shares includes unvested RSUs, which limits immediate liquidity but retains potential future dilution upon vesting. This single, small transaction is unlikely to affect the company’s market valuation or signal insider sentiment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Miller Laurie A.

(Last) (First) (Middle)

125 SUMMER STREET

(Street)

BOSTON MA 02110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HAEMONETICS CORP [ HAE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		F		238(1)	D	$49.95	28,925(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

2. This number includes unvested RSUs previously reported.

	/s/ Thomas V. Powers, attorney-in-fact for Ms. Miller	09/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Laurie A. Miller report on the Form 4 for HAE?

The Form 4 reports a tax-withholding disposition of 238 shares on 09/17/2025 and a remaining beneficial ownership of 28,925 shares.

Why were 238 shares disposed according to the filing?

The filing explains the 238-share disposition represents shares withheld to satisfy tax obligations in connection with the vesting of previously granted RSUs.

What price was shown for the disposed shares in the Form 4?

The transaction is reported at a price of $49.95 per share.

Does the Form 4 show a change in Ms. Miller’s role at HAE?

No; the filing identifies Laurie A. Miller as SVP, Human Resources and indicates an officer reporting relationship but does not report any role change.

Who signed the Form 4 and when?

The Form 4 was signed by attorney-in-fact Thomas V. Powers on 09/24/2025.